Home›Breast Cancer›Phase III ASCENT Study of Metastatic TNBC Halted Due to Compelling Efficacy

Phase III ASCENT Study of Metastatic TNBC Halted Due to Compelling Efficacy

October 10, 2024

1203

[ad_1]

The decision to halt the study was based on the unanimous recommendation by an independent data safety monitoring committee during its routine review of the ASCENT study.

[ad_2]

Fitcoachion

At this moment, I am a doctor and a health blogger. I wrote my first blog post in 2008 about a new symptom I had experienced with my skin. By 2011, I was writing almost weekly about medical topics and had become a contributing writer at fitcoachion.com. It didn't take me long to realize that this was what I wanted to do for the rest of my life. In 2014, I started working as a doctor and have written more than 25,000 words in that capacity. In addition to working as a doctor, I have also worked as a public relations specialist and as an English tutor.